CytomX Therapeutics Lands $30,000,000 New Financing

  • Feed Type
  • Date
    9/23/2010
  • Company Name
    CytomX Therapeutics
  • Mailing Address
    460 Ward Dr. Santa Barbara, CA 93111
  • Company Description
    CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodies, proteolytically-activated antibodies.
  • Website
    http://www.cytomx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds from the financing will be used to advance the company’s unique antibody platform, expand the team and move the company to the Bay Area by the end of 2010.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Roche Venture Fund

By posting a comment, you agree to our terms and conditions.